On Feb. 20, Shire Pharmaceuticals
- Revenue for the quarter increased by 6.9%, with flagship product Adderal XR leading the way.
- The company expects revenue growth of 20% in 2007, assuming the attention deficit and hyperactivity disorder (ADHD) market grows by 4% to 6%.
- Shire Pharmaceuticals plans to acquire New River Pharmaceuticals
(NASDAQ:NRPH) for $2.6 billion cash to gain full control of VYVANSE, a future product for ADHD. - Our Motley Fool CAPS community doesn't think Shire is anything special, granting it a middle-of-the-road three-star rating.
(Figures in millions, except per-share data)
Income Statement Highlights
|
Q4 2006 |
Q4 2005 |
Change |
|
|---|---|---|---|
|
Sales |
$497.0 |
$464.9 |
6.9% |
|
Net Profit |
$68.6 |
$69.0 |
(0.5%) |
|
EPS* |
$0.40 |
$0.41 |
(7.1%) |
|
Diluted Shares |
510.3 |
504.1 |
1.2% |
Get back to basics with a look at the income statement.
Margin Checkup
Q4 2006 | Q4 2005 | Change* | |
|---|---|---|---|
Gross Margin | 87.4% | 83.0% | 4.5 |
Operating Margin | 16.2% | 20.4% | (4.3) |
Net Margin | 13.8% | 15.1% | (1.3) |
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
Assets | Q4 2006 | Q4 2005 | Change |
|---|---|---|---|
Cash + ST Invest. | $1,126.9 | $663.4 | 69.9% |
Accounts Rec. | $310.8 | $329.9 | (5.8%) |
Inventory | $131.1 | $136.0 | (3.6%) |
Liabilities | Q4 2006 | Q4 2005 | Change |
|---|---|---|---|
Accounts Payable | $566.1 | $431.8 | 31.1% |
Long-Term Debt | No data | No data | No data |
Learn the ways of the balance sheet.
Cash Flow Highlights
Q4 2006 | Q4 2005 | Change | |
|---|---|---|---|
Cash From Ops. | $188.8 | $155.0 | 21.8% |
Capital Expenditures | $29.1 | $28.6 | 1.7% |
Free Cash Flow | $159.7 | $126.4 | 26.3% |
Find out why Fools always follow the money.
Related Foolishness:
Need new ideas for your money? Investors like you rate thousands of stocks on Motley Fool CAPS to help you with your own stock selections. It's fun --and it's free.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.
